Botulism clinical trials
The registry lists 21 studies for Botulism across 4 countries. 3 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-07-30.
Status
- Completed
- 16
- Enrolling by invitation
- 1
- Not yet recruiting
- 1
- Status unknown
- 1
- Withdrawn
- 1
- Recruiting
- 1
Phase
- Phase 1
- 6
- Phase 2
- 6
- Phase 3
- 3
- Phase 4
- 1
Where
- United States
- 11
- Thailand
- 2
- France
- 2
- Taiwan
- 1
Who runs them
Emergent BioSolutions (3) · California Department of Public Health (3) · National Institute of Allergy and Infectious Diseases (NIAID) (3) · DynPort Vaccine Company LLC, A GDIT Company (2) · Rajavithi Hospital (2) · California Department of Health Services (1) · Wake Forest University Health Sciences (1) · Centre Hospitalier Universitaire, Amiens (1)
Studies
Recruiting first, then most recently updated. Showing 21 of 21 — search for more.
- BT-011 Pharmacokinetics of Botulism Antitoxin Heptavalent in Pediatric PatientsEnrolling by invitationNCT02051062Phase 4
- Injection of Botulinum Toxin for Thumb Carpometacarpal ArthritisRecruitingNCT05990881Phase 31 country
- Study of the Drug B11-FC (Botulism Treatment)Not yet recruitingNCT06580236Phase 1/2
- Tolerability and Immunogenicity of a Single 40-ug Dose of rBV A/B for the Production of BabyBIG®CompletedNCT06112834Phase 21 country
- Retrospective Epidemiological Study on Botulism in Intensive Care Units in FranceCompletedNCT036589021 country
- Pilot Study on the Usefulness of 3,4-diaminopyridine in the Treatment of BotulismCompletedNCT01441557Phase 2/31 country
- Effect of Amifampridine on Neuromuscular Transmission in Patients Treated With OnabotulinumtoxinACompletedNCT05769478Phase 11 country
- Botulism Antitoxin Effects on Paralysis Induced by Botulinum Neurotoxins in the EDB MuscleCompletedNCT00636519Phase 11 country
- BT-010 Registry for the Evaluation of Safety and Clinical Outcomes in Patients Treated With Botulinum AntitoxinCompletedNCT02055183
- A Study to Evaluate the Safety and Pharmacokinetics of NTM-1633 vs Placebo Administered Intravenously in Healthy AdultsCompletedNCT03603665Phase 11 country
- Tolerability and Immunogenicity of rBV A/B for the Production of BabyBIG®CompletedNCT03676634Phase 21 country
- Using Shear Wave Ultrasound Elastography for Follow up After Anti-spastic Intervention Among Stroke PatientsStatus unknownNCT045507931 country
- A Pilot Study of Constraint Induced Movement Therapy in Preschool Cerebral Palsy After Botulism Toxin InjectionCompletedNCT04179682Not applicable
- Phase 3, Randomized, Safety, Lot Consistency and Clinical Benefit Study of Recombinant Botulinum Vaccine A/BWithdrawnNCT01940315Phase 3
- Phase I, Dose Escalation Study to Evaluate the Safety and Pharmacokinetics of NTM-1632CompletedNCT02779140Phase 11 country
- Safety, Tolerability, and Immunogenicity Study of Investigational Recombinant Botulinum Vaccine A/B (rBV A/B) in Volunteers Previously Immunized With Investigational Pentavalent Botulinum ToxoidCompletedNCT01701999Phase 21 country
- Study of Human Botulism Immunoglobulin in Infants With BotulismCompletedNCT00004401Not applicable1 country
- Phase 1 PK Study of XOMA 3ABCompletedNCT01357213Phase 11 country
- Double Blind, Safety and Immunogenicity Study of Recombinant Botulinum Vaccine A/BCompletedNCT00764634Phase 21 country
- Treatment of Survivors After Botulism OutbreakCompletedNCT003140801 country
- Botulism Outbreak in Thailand (Episode II)CompletedNCT003484261 country